3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
10
Colorectal Neoplasms
5
Stomach Neoplasms
3
Rhabdomyosarcoma
3
Osteosarcoma
3
Biliary Tract Neoplasms
3
Sarcoma, Ewing
2
Recurrence
2
Rectal Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Wilms Tumor
1
Small Cell Lung Carcinoma
1
Small Bowel Adenocarcinoma
1
Sarcoma
1
Rhabdoid Tumor
1
Rectal Cancer Patients
1
Peritoneal Neoplasms
1
PDAC - Pancreatic Ductal Adenocarcinoma
1
Ovarian Neoplasms
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Neuroblastoma
1
Nasopharyngeal Carcinoma
1
Metastatic Gastric Adenocarcinoma
1
Metastatic Adenocarcinoma of the Pancreas
1
Malignant Ascites
1
Hepatoblastoma
1
Gastrointestinal Neoplasms
1
Gastroesophageal Junction Adenocarcinoma
1
Gastro-enteropancreatic neuroendocrine tumor
1
Interventions
Mitomycin
6
Leucovorin
4
Fluorouracil
4
Oxaliplatin
3
dehydroftorafur
2
Mitozytrex
2
Irinotecan
2
Hyperthermic Intraperitoneal Chemotherapy
2
Doxorubicin
2
Cisplatin
2
Biopsy
2
surufatinib
1
sodium thiosulfate
1
sintilimab
1
nilotinib
1
irinotecan sucrosofate
1
Surveys and Questionnaires
1
Specimen Handling
1
Platinum
1
Pafolacianine
1
Paclitaxel
1
Magnetic Resonance Spectroscopy
1
Laparoscopy
1
Immunoglobulin G
1
Floxuridine
1
Electrocardiography
1
Disulfides
1
Cytoreduction Surgical Procedures
1
Cryotherapy
1
Cetuximab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Appendiceal Neoplasms
×
irinotecan sucrosofate
×
1 year
×
Clear all
NCT05277766
2025-07-01
PIPAC-NAL-IRI
University Hospital, Ghent
Phase 1
Recruiting
45 enrolled